Search
for
Sort by
Research 271–300 of 321
- Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors
- Role of Dutasteride in the Treatment of Androgenetic Alopecia
- Correlation between sebum level and severity of male androgenetic alopecia
- Medical Management Options for Hair Loss
- Phytochemical, Toxicological and Pharmacological Studies of <i>Asiasari Radix</i> et Rhizoma: A Review
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- Finasteride and sexual side effects
- Comparison of clinical trials with finasteride and dutasteride.
- Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Phytotherapy in Trichology: A Review
- Quercetin Nanocrystal Gel: A Novel Topical Therapeutic Strategy for Androgenetic Alopecia
- Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in treatment of male androgenic alopecia
- Effects of the use of finasteride on prostate volume and serum PSA in young patients
- Scalp Biophysical Characteristics in Males with Androgenetic Alopecia: A Comparative Study with Healthy Controls
- Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials
- Identification of A p300–SP1–BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome
- The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
- Evaluation of the safety and efficacy of concentrated growth factors for hair growth promotion in androgenetic alopecia patients: A retrospective single‐centre, single‐arm study
- Hair Follicle Stem Cells and Hair Regeneration
- Antioxidant and 5α-Reductase Inhibitory Activity of Momordica charantia Extract, and Development and Characterization of Microemulsion
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Manage androgenetic alopecia in men with established options but emerging therapies show promise